Age-related Macular Degeneration

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-Related Macular Degeneration Trial in Iowa City, Baltimore, Portland (RetinoStat)

Active, not recruiting
  • Age-Related Macular Degeneration
  • Iowa City, Iowa
  • +2 more
Oct 20, 2021

Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)

Terminated
  • Age-Related Macular Degeneration
  • Gilbert, Arizona
  • +206 more
Sep 29, 2020

Choroidal Neovascularization, Age-related Macular Degeneration Trial in United States (hI-con1, ranibizumab, Sham injection)

Completed
  • Choroidal Neovascularization
  • Age-related Macular Degeneration
  • hI-con1
  • +2 more
  • Phoenix, Arizona
  • +47 more
Sep 23, 2020

Age-related Macular Degeneration Trial in Baltimore (VMS diary booklet, Standard of Care)

Terminated
  • Age-related Macular Degeneration
  • VMS diary booklet
  • Standard of Care
  • Baltimore, Maryland
    Johns Hopkins University Wilmer Eye Institute
Aug 12, 2019

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
  • Age-Related Macular Degeneration
  • Tucson, Arizona
  • +120 more
Aug 13, 2018

Age-related Macular Degeneration, Subfoveal Choroidal Neovascularization, Subretinal Scarring Trial in Baltimore (RXI-109)

Unknown status
  • Age-related Macular Degeneration
  • +3 more
  • Baltimore, Maryland
    Wilmer Eye Institute at Johns Hopkins
Feb 22, 2018

Combretastatin A4 Phosphate, Age-related Macular Degeneration, AMD Trial in Baltimore (Combretastatin A-4 phosphate,

Completed
  • Combretastatin A4 Phosphate
  • +4 more
  • Combretastatin A-4 phosphate
  • Combretastatin A-4 Phosphate
  • Baltimore, Maryland
    Wilmer Eye Institute
Dec 4, 2017

Precision of the Microperimetry Function of the Spectral OCT/SLO

Completed
  • Age-Related Macular Degeneration
  • +8 more
    • Fort Lauderdale, Florida
    • +2 more
    Apr 3, 2017

    Age-related Macular Degeneration Trial in United States (Squalamine lactate ophthalmic solution, 0.2%, Placebo Ophthalmic

    Unknown status
    • Age-related Macular Degeneration
    • Squalamine lactate ophthalmic solution, 0.2%
    • +2 more
    • Mobile, Alabama
    • +117 more
    Apr 25, 2017

    Age-related Macular Degeneration Trial in United States (Ranibizumab 0.5mg)

    Unknown status
    • Age-related Macular Degeneration
    • Ranibizumab 0.5mg
    • Mountain View, California
    • +3 more
    Aug 1, 2016

    Age-related Macular Degeneration Trial in United States (Ranibizumab)

    Completed
    • Age-related Macular Degeneration
    • Phoenix, Arizona
    • +98 more
    Dec 11, 2012

    Age-Related Macular Degeneration Trial in Israel, United States (PF-04523655)

    Completed
    • Age-Related Macular Degeneration
    • Beverly Hills, California
    • +10 more
    Oct 5, 2012

    Age-Related Macular Degeneration Trial in United States (Avastin, Photodynamic Therapy (PDT), Preservative-Free Triamcinolone

    Terminated
    • Age-Related Macular Degeneration
    • Ft. Lauderdale, Florida
    • +10 more
    Mar 23, 2010

    Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Baltimore, Cleveland (AGN211745)

    Completed
    • Age-Related Macular Degeneration
    • Choroidal Neovascularization
    • Baltimore, Maryland
    • +1 more
    Aug 14, 2008

    Choroidal Neovascularization, Age-Related Macular Degeneration Trial in Baltimore, Portland (Periocular injection of

    Completed
    • Choroidal Neovascularization
    • Age-Related Macular Degeneration
    • Periocular injection of triamcinolone acetonide 40mg
    • Baltimore, Maryland
    • +1 more
    Mar 20, 2006